Ads
related to: Vertex
Search results
Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know
Zacks via Yahoo Finance· 1 day agoThe most recent trading session ended with Vertex Pharmaceuticals (VRTX) standing at $394.17,...
Don't miss the last chance to grab tickets for Vertex 2024
Creative Bloq via Yahoo News· 12 hours agoVertex 2024 logo. Vertex 2024, the ultimate in-person event for 2D and 3D digital art, will bring...
Is Vertex (VRTX) a Buy as Wall Street Analysts Look Optimistic?
Zacks via Yahoo Finance· 1 day agoAccording to the average brokerage recommendation (ABR), one should invest in Vertex (VRTX). It is...
Koshinski Asset Management Inc. Sells 1,004 Shares of Vertex Pharmaceuticals Incorporated...
ETF DAILY NEWS· 18 hours agoKoshinski Asset Management Inc. trimmed its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 66.8% in the fourth quarter, according ...
Vertex Pharma scientist talks about the long road to developing non-addictive painkillers
ABC News· 2 days agoOpioid prescriptions have plummeted over the last decade as doctors have become more attuned to the...
Vertex Pharmaceuticals (NASDAQ:VRTX) Upgraded to “Strong-Buy” at StockNews.com
ETF DAILY NEWS· 5 days agoRoyal Bank of Canada lifted their price objective on Vertex Pharmaceuticals from $397.00 to $420.00 and gave the stock a sector perform rating in a research report on Tuesday ...
Vertex Pharmaceuticals: Buy, Sell, or Hold?
Motley Fool via Yahoo Finance· 6 days agoVertex Pharmaceuticals (NASDAQ: VRTX) has a promising healthcare business with many growth opportunities ahead. But with the stock such a hot buy over...
Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $462.00
ETF DAILY NEWS· 4 days agoVertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price objective lifted by HC Wainwright from $457.00 to $462.00 in a research report released on Thursday, Benzinga ...
Here's (at Least) 1 new Reason to Buy Vertex Pharmaceuticals Stock
Motley Fool via Yahoo Finance· 2 days agoBiotech acquisitions continue to abound this year. On April 10, Vertex Pharmaceuticals (NASDAQ:...
Alpine Immune stock downgraded by Leerink Partners after Vertex acquisition
Investing.com· 6 days agoAlpine Immune stock downgraded by Leerink Partners after Vertex acquisition
